Skip to main content
OpenTrials

Clinical trial condition

KRAS P.G12C

Explore clinical trials studying KRAS P.G12C. Study availability and eligibility vary by location and protocol.

7 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

KRAS P.G12C trial results

Recruiting

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

NCT05410145

Conditions
KRAS P.G12C
Locations
  • D3 Bio Investigative Site 0402 Orange, California, United States
  • D3 Bio Investigative Site 0407 Palo Alto, California, United States
  • D3 Bio Investigative Site 0404 Denver, Colorado, United States
  • D3 Bio Investigative Site 0406 Sarasota, Florida, United States
View all 52 locations
View Trial Details
Recruiting

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

NCT05288205

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Pecking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy Of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tiantan Hospital, Captal Medical University Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 20 locations
View Trial Details
Recruiting

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

NCT06008288

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgung Hospital Beijing, Beijing Municipality, China
View all 31 locations
View Trial Details
Active, not recruiting

Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

NCT05673187

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Instiute Jules Bordet Brussels, Belgium
  • Le Mans - CHG Le Mans, France
  • Hôpital de Marseille Marseille, France
  • Beaumont Hospital Dublin, Ireland
View all 18 locations
View Trial Details

Related conditions